SEC Form 4 research
| Issuer | Elevance Health, Inc. |
|---|---|
| Tickers | ELV, WLP, ANTM |
| Reporting owners | 79 |
| Officers and directors | 54 |
| Last public filing | 2026-11-06 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-11-06 | 2026-11-05 | LAVU RATNAKAR | S | 1,300 | $440 | Not reported |
| 2026-10-23 | 2026-10-22 | Kaye Mark | S | 480 | $442.61 | Not reported |
| 2026-10-23 | 2026-10-22 | Kaye Mark | S | 2,343 | $441.34 | Not reported |
| 2026-10-23 | 2026-10-22 | Kaye Mark | S | 1,720 | $440.44 | Not reported |
| 2026-10-23 | 2026-10-22 | Kaye Mark | S | 1,160 | $439.25 | Not reported |
| 2026-10-23 | 2026-10-22 | Kaye Mark | S | 240 | $438.22 | Not reported |
| 2026-10-23 | 2026-10-22 | Kaye Mark | S | 560 | $437.07 | Not reported |
| 2026-10-23 | 2026-10-22 | Kaye Mark | S | 1,660 | $436.2 | Not reported |
| 2026-10-23 | 2026-10-22 | Kaye Mark | S | 321 | $435.25 | Not reported |
| 2026-10-23 | 2026-10-22 | Kaye Mark | S | 273 | $447.19 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.